CRIO Welcomes Jonathan Andrus as President & COO

Company Strengths Executive Management Team with Senior Industry Expert

BOSTON, MA – April 19, 2022 – Clinical Research IO (CRIO), a Boston-based technology firm streamlining clinical trials for sponsors, sites, and patients, announced that Jonathan Andrus will join as President and Chief Operating Officer. Working collaboratively with the CRIO senior team, Andrus will focus on operational excellence and continuing to expand CRIO’s presence in the life science industry.

“CRIO is at an inflection point as we take our success with site-based software to sponsors and patients. We are thrilled to have someone of Jonathan’s domain expertise and character join CRIO,” said Raymond Nomizu, CEO and co-founder at CRIO. “We are changing the way clinical trials are run. Jonathan brings tremendous experience and vision to our team and will be a great asset as we continue to scale our organization to drive accelerated growth for CRIO.”

Mr. Andrus brings over 25 years of executive management, operational, quality, and business experience to CRIO. Most recently he served as Chief Strategy Officer for Clinical Ink. Prior to that, he served as Senior Vice President for BioClinica (now Clario), where he led the e-clinical operations and data management teams. His early career includes experience in pharmaceutical consulting and contract research organizations. Andrus serves on the board and executive committee of the Society for Clinical Data Management (SCDM), is a co-lead with the Decentralized Trials and Research Alliance (DTRA) workstream initiative, serves as co-author on upcoming eCOA Consortium publications, and has been on the advisory boards of CDISC and DIA.

“I share Raymond’s vision of bringing the efficiency of eSource to sponsors and CROs. CRIO is uniquely positioned to provide solutions for modern clinical trials. With the ability to support decentralized clinical trials and hybrid trials, CRIO is the only vendor providing solutions for sites, sponsors, and patients. COVID forced the industry to rethink how clinical trials are run and CRIO’s eSource platform was the perfect solution to address this challenge. I am excited to join the CRIO team and look forward to building on the solid foundation they have already established,” said Andrus, President & COO at CRIO.

About CRIO

Innovation is at the heart of everything we do. Our mission is to streamline clinical research to bring new medications to market faster. We have created a holistic paperless platform for conducting clinical trials that will reduce data errors, streamline regulatory workflows and accelerate timelines. Today, CRIO supports more than 1000 medical research sites worldwide. For more information about CRIO, visit clinicalresearch.io.

Media Contact:

Stephen Boccardo, Sr. VP Sales

(857) 957-5376

stephen.boccardo@clinicalresearch.io

CRIO Bugathon – Building the Ultimate Platform

While bugs are as natural in coding as they are in nature, we don’t want them creeping into our code. At CRIO, we have established various processes and procedures to handle bugs. At the close of 2022, we hosted a Bugathon, part of our ongoing efforts to deliver best-in-class quality. The Bugathon was a two...

CRIO Welcomes Dr. Margaretta Nyilas to its Board of Directors

BOSTON, MA – November 3, 2022 – CRIO, the industry’s leading eSource provider, announces the appointment of Dr. Margaretta Nyilas to its Board of Directors, effective immediately. Dr. Nyilas is a biopharmaceutical executive with over twenty years of diverse global industry experience, formerly at Otsuka Pharmaceuticals, Bristol Myers Squibb and Click Therapeutics. She has a...

3 Reasons to Visit CRIO at SCRS 2022

SCRS 2022 starts next week. Here are 3 reasons to stop by Booth 401 and meet Team CRIO. We’ll see you there! Friday, Oct.7 at 10:30 am. Master Workshop #1 : How the World’s Leading Vaccine Network Reduced Protocol Deviations by 40% 2. Meet the team behind the industry’s leading site-based eSource technology. CRIO delivers...